α-1-acid glycoprotein as a predictive biomarker for severe neutropenia induced by docetaxel in esophageal carcinoma

被引：0
作者：
Sasaki, Yusuke [1 ]
Kato, Ken [1 ]
Shoji, Hirokazu [1 ]
Iwasa, Satoru [1 ]
Hamaguchi, Tetsuya [1 ]
Boku, Narikazu [1 ]
机构：
[1] Natl Canc Ctr, Gastrointest Oncol Div, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
alpha 1 acid glycoprotein; Docetaxel;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2249
引用
收藏
页码：692 / 692
页数：1
相关论文
共 25 条
  • [21] RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin
    Park, Yong
    Kim, Dae S.
    Park, Kyong H.
    Baek, Seung-Kuk
    Kwon, Soon Y.
    Shin, Sang W.
    Jung, Kwang Y.
    Kim, Chul Y.
    Kim, Yeol H.
    Lee, Nam J.
    Kim, Jun S.
    Kim, In S.
    ONKOLOGIE, 2012, 35 (11): : 673 - 682
  • [22] Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line
    Francesco Fabbri
    Giovanni Brigliadori
    Silvia Carloni
    Paola Ulivi
    Ivan Vannini
    Anna Tesei
    Rosella Silvestrini
    Dino Amadori
    Wainer Zoli
    Journal of Translational Medicine, 6
  • [23] A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
    Qi Liu
    Yi Xia
    Yun Chen
    Junhua Zhang
    Jiaying Deng
    Kuaile Zhao
    Radiation Oncology, 15
  • [24] A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
    Liu, Qi
    Xia, Yi
    Chen, Yun
    Zhang, Junhua
    Deng, Jiaying
    Zhao, Kuaile
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [25] Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145
    Yuksel Kucukzeybek
    Mustafa K Gul
    Ercument Cengiz
    Cigdem Erten
    Burcak Karaca
    Gurbuz Gorumlu
    Harika Atmaca
    Selim Uzunoglu
    Bulent Karabulut
    Ulus A Sanli
    Ruchan Uslu
    Journal of Experimental & Clinical Cancer Research, 27
123